The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 2

Demographics and medical history of the participants ().

	Treatment	Male	Female	Subtotal
Gender, (% of subtotal)	BrainPower	14 (29.8%)	33 (70.2%)	47 (100%)
	Placebo	17 (33.3%)	34 (66.7%)	51 (100%)
	Combined	31 (31.6%)	69 (68.4)	98 (100%)
Age, year (mean ± s.d.)	BrainPower	69.68 ± 9.52	68.80 ± 9.60
	Placebo	64.03 ±10.73	65.81 ± 11.41
	Combined	69.07 ± 9.48	65.22 ± 11.1	67.07 ± 10.49
Age, year (range)	BrainPower	52.87–82.80	53.18–84.86
	Placebo	47.28–83.47	49.03–88.43
	Combined	52.87–84.46	47.28–88.43	47.28–88.43
History of chronic disease, yes/total (%)	BrainPower	39/47 (83.0%)
	Placebo	31/51 (60.8%)
	Combined	70/98 (71.4%)
History of alcohol use, yes/total (%)	BrainPower	5/47 (10.6%)
	Placebo	8/51 (15.7%)
	Combined	13/98 (13.3%)
History of medication, yes/total (%)	BrainPower	35/47 (74.5%)
	Placebo	23/51 (45.1%)
	Combined	58/98 (59.2%)